|
US6696475B2
(en)
|
1997-04-22 |
2004-02-24 |
Neurosearch A/S |
Substituted phenyl derivatives, their preparation and use
|
|
HU227711B1
(en)
*
|
1997-12-22 |
2011-12-28 |
Bayer Healthcare Llc |
Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas and pharmaceutical compositions containing them
|
|
CN1263733C
(zh)
|
1998-10-22 |
2006-07-12 |
神经研究公司 |
取代苯基衍生物,它们的制备和用途
|
|
US20050080112A1
(en)
*
|
2001-06-22 |
2005-04-14 |
Madsen Lars Siim |
Compounds for use in disorders associated with mast cell or basophil acitvity
|
|
US7087631B2
(en)
*
|
2002-07-18 |
2006-08-08 |
Inotek Pharmaceuticals Corporation |
Aryltetrazole compounds, and compositions thereof
|
|
US7078423B2
(en)
*
|
2002-07-18 |
2006-07-18 |
Inotek Pharmaceuticals Corporation |
5-Aryltetrazole compounds, compositions thereof, and uses therefor
|
|
CA2493253A1
(en)
*
|
2002-08-01 |
2004-02-12 |
Neurosearch A/S |
Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy
|
|
WO2004022525A1
(en)
*
|
2002-09-05 |
2004-03-18 |
Neurosearch A/S |
Amide derivatives and their use as chloride channel blockers
|
|
WO2004022529A2
(en)
*
|
2002-09-05 |
2004-03-18 |
Neurosearch A/S |
Diarylurea derivatives and their use as chloride channel blockers
|
|
US7041693B2
(en)
*
|
2002-10-04 |
2006-05-09 |
Bristol-Myers Squibb Company |
Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)
|
|
JP2006507329A
(ja)
|
2002-11-21 |
2006-03-02 |
ニューロサーチ、アクティーゼルスカブ |
新規アリールウレイド安息香酸誘導体及びその使用
|
|
US20060229335A1
(en)
*
|
2002-12-24 |
2006-10-12 |
Bradley Teegarden |
Diarylamine and arylheteroarylamine pyrazole derivatives as modulators of 5ht2a
|
|
JP2006527735A
(ja)
*
|
2003-06-17 |
2006-12-07 |
ノイロサーチ アクティーゼルスカブ |
ジフェニル尿素誘導体、及びクロライドチャネル遮断剤としてのそれらの使用
|
|
HRP20060100T3
(en)
|
2003-07-22 |
2007-03-31 |
Arena Pharmaceuticals Inc |
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
|
|
US7202363B2
(en)
|
2003-07-24 |
2007-04-10 |
Abbott Laboratories |
Thienopyridine and furopyridine kinase inhibitors
|
|
WO2005023238A1
(en)
*
|
2003-09-04 |
2005-03-17 |
Poseidon Pharmaceuticals A/S |
Erg channel openers for the treatment of hyperexcitability-related neuronal diseases
|
|
CN1845726A
(zh)
|
2003-09-04 |
2006-10-11 |
波塞东医药公司 |
用于治疗心脏心律失常的erg通道开放剂
|
|
JP2007509846A
(ja)
*
|
2003-10-15 |
2007-04-19 |
バイエル・ヘルスケア・アクチェンゲゼルシャフト |
テトラヒドロ−ナフタレンおよび尿素誘導体
|
|
JP2007528420A
(ja)
*
|
2004-03-11 |
2007-10-11 |
グラクソ グループ リミテッド |
新規ｍ３ムスカリン性アセチルコリン受容体アンタゴニスト
|
|
CN1926114B
(zh)
*
|
2004-03-23 |
2011-08-24 |
艾尼纳制药公司 |
用于制备经取代n-芳基-n′-′3-(1h-吡唑-5-基)苯基脲及其中间体的方法
|
|
SA05260357B1
(ar)
*
|
2004-11-19 |
2008-09-08 |
ارينا فارماسيتو تيكالز ، أنك |
مشتقات 3_فينيل_بيرازول كمعدلات لمستقبل سيروتينين 5_ht2a مفيدة في علاج الاضطرابات المتعلقه به
|
|
US20070078121A1
(en)
*
|
2004-12-23 |
2007-04-05 |
Flynn Daniel L |
Enzyme modulators and treatments
|
|
USRE45336E1
(en)
|
2006-05-18 |
2015-01-13 |
Arena Pharmaceuticals, Inc. |
Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
|
|
WO2007136689A2
(en)
|
2006-05-18 |
2007-11-29 |
Arena Pharmaceuticals, Inc. |
Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-ht2a serotonin receptor
|
|
CA2646076C
(en)
|
2006-05-18 |
2015-06-30 |
Arena Pharmaceuticals, Inc. |
Ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
|
TWI415845B
(zh)
*
|
2006-10-03 |
2013-11-21 |
Arena Pharm Inc |
用於治療與５-ｈｔ2ａ血清素受體相關聯病症之作為５-ｈｔ2ａ血清素受體之調節劑的吡唑衍生物
|
|
US7790756B2
(en)
*
|
2006-10-11 |
2010-09-07 |
Deciphera Pharmaceuticals, Llc |
Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
|
|
US20100137381A1
(en)
|
2007-05-03 |
2010-06-03 |
Neurosearch A/S |
Acetamide derivatives as potassium channel modulators
|
|
EP2190844B3
(en)
|
2007-08-15 |
2013-07-17 |
Arena Pharmaceuticals, Inc. |
Imidazo[1,2-a]pyridine derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
|
WO2009123714A2
(en)
*
|
2008-04-02 |
2009-10-08 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
|
|
WO2010062321A1
(en)
|
2008-10-28 |
2010-06-03 |
Arena Pharmaceuticals, Inc. |
Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto
|
|
TR201805216T4
(en)
|
2008-10-28 |
2018-06-21 |
Arena Pharm Inc |
COMPOSITIONS OF A USEFUL 5-HT2A SEROTONINE RECEPTOR MODULATOR FOR THE TREATMENT OF RELATED DISORDERS
|
|
KR101639642B1
(ko)
|
2008-12-05 |
2016-07-14 |
애브비 바하마스 리미티드 |
암 치료에 사용하기 위한 키나제 억제제로서의 티에노［3,2-ｃ］피리딘 유도체
|
|
WO2011075596A1
(en)
|
2009-12-18 |
2011-06-23 |
Arena Pharmaceuticals, Inc. |
Crystalline forms of certain 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
|
WO2013012909A1
(en)
|
2011-07-20 |
2013-01-24 |
Abbott Laboratories |
Kinase inhibitor with improved aqueous solubility
|
|
CN103709185A
(zh)
*
|
2013-12-30 |
2014-04-09 |
大连联化医药技术有限公司 |
一种4-(n-甲基甲酰氨)苯基硼酸的制备方法
|
|
JP2018516992A
(ja)
|
2015-06-12 |
2018-06-28 |
アクソファント サイエンシーズ ゲーエムベーハーＡｘｏｖａｎｔ Ｓｃｉｅｎｃｅｓ Ｇｍｂｈ |
レム睡眠行動障害の予防および処置のために有用なジアリールおよびアリールヘテロアリール尿素誘導体
|
|
WO2017011767A2
(en)
|
2015-07-15 |
2017-01-19 |
Axovant Sciences Ltd. |
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease
|
|
SI3622953T1
(sl)
|
2016-05-17 |
2021-05-31 |
Scandion Oncology A/S |
Kombinirano zdravljenje raka
|
|
WO2019014352A1
(en)
|
2017-07-11 |
2019-01-17 |
Vertex Pharmaceuticals Incorporated |
CARBOXAMIDES AS INHIBITORS OF SODIUM CHANNELS
|
|
WO2020146682A1
(en)
|
2019-01-10 |
2020-07-16 |
Vertex Pharmaceuticals Incorporated |
Carboxamides as modulators of sodium channels
|
|
US12440481B2
(en)
|
2019-01-10 |
2025-10-14 |
Vertex Pharmaceuticals Incorporated |
Esters and carbamates as modulators of sodium channels
|
|
CN117229258B
(zh)
*
|
2022-06-07 |
2024-07-19 |
杭州壹瑞医药科技有限公司 |
N-四唑基芳基脲类衍生物及其制备方法和应用
|